Genetic testing in the European Union: does economic evaluation matter?
about
Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature.Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol.Implementing personalized medicine with asymmetric information on prevalence rates.Toward health technology assessment of whole-genome sequencing diagnostic tests: challenges and solutions
P2860
Genetic testing in the European Union: does economic evaluation matter?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic testing in the European Union: does economic evaluation matter?
@en
Genetic testing in the European Union: does economic evaluation matter?
@nl
type
label
Genetic testing in the European Union: does economic evaluation matter?
@en
Genetic testing in the European Union: does economic evaluation matter?
@nl
prefLabel
Genetic testing in the European Union: does economic evaluation matter?
@en
Genetic testing in the European Union: does economic evaluation matter?
@nl
P2093
P2860
P1476
Genetic testing in the European Union: does economic evaluation matter?
@en
P2093
Fernando Antoñanzas
M F Hutter
M Pinillos
R Rodríguez-Ibeas
P2860
P2888
P304
P356
10.1007/S10198-011-0319-X
P577
2011-05-20T00:00:00Z